Oculis Holding AG (OCS) Beginning Cash Balance (2023 - 2026)
Oculis Holding AG (OCS) posted quarterly Beginning Cash Balance of $103.9 million for Q1 2026, up 237.0% year-over-year from $30.8 million in Q1 2025, and up 237.0% quarter-over-quarter from $30.8 million in Q1 2025.
Oculis Holding AG (OCS) Beginning Cash Balance (2023 - 2026) Analysis & Trends
Oculis Holding AG's Beginning Cash Balance history runs 4 years deep, the most recent figure standing at $103.9 million for Q1 2026.
- In Q1 2026, Beginning Cash Balance rose 237.0% year-over-year to $103.9 million; the TTM figure through Mar 2026 stood at $103.9 million (up 237.0% YoY), while the FY2025 annual figure was $33.4 million, down 23.29% from the prior year.
- Beginning Cash Balance for Q1 2026 stood at $103.9 million, up from $30.8 million in the prior quarter.
- The five-year high for Beginning Cash Balance was $103.9 million in Q1 2026, with the low at $21.4 million in Q1 2023.
- The 4-year median for Beginning Cash Balance is $37.4 million (2024), against an average of $50.0 million.
- The sharpest annual moves came in 2025 and 2026: Beginning Cash Balance decreased 29.82% in 2025, then jumped 237.0% in 2026.
- Oculis Holding AG's Beginning Cash Balance stood at $21.4 million in 2023, then surged by 105.27% to $43.9 million in 2024, then dropped by 29.82% to $30.8 million in 2025, then soared by 237.0% to $103.9 million in 2026.
- Business Quant data shows OCS's Beginning Cash Balance at $103.9 million in Q1 2026, $30.8 million in Q1 2025, and $43.9 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Oculis Holding AG | 879.09 Mn | 590.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.86 Mn |
| Mar 31, 2026 | 103.86 Mn |
| Mar 31, 2025 | 30.82 Mn |
| Mar 31, 2025 | 30.82 Mn |
| Mar 31, 2024 | 43.91 Mn |
| Mar 31, 2024 | 43.91 Mn |
| Mar 31, 2023 | 21.39 Mn |
| Mar 31, 2023 | 21.39 Mn |